Background An accurate and affordable CD4+ T cells count is an essential tool in the fight against HIV/ AIDS. Flow cytometry (FCM) is the “gold standard ” for counting such cells, but this tech-nique is expensive and requires sophisticated equipment, temperature-sensitive monoclo-nal antibodies (mAbs) and trained personnel. The lack of access to technical support and quality assurance programs thus limits the use of FCM in resource-constrained countries. We have tested the accuracy, the precision and the carry-over contamination of Partec CyFlow MiniPOC, a portable and economically affordable flow cytometer designed for CD4+ count and percentage, used along with the “CD4 % Count Kit-Dry”. Materials and Methods Venous blood from 59 adult HIV...
Backround: HIV monitoring in resource-constrained settings demands affordable and reliable CD4+ T ly...
Abstract Background The World Health Organization (WHO)'s "3 × 5 program" has spurred efforts to pla...
BackgroundCD4 T-cell counts are still widely used to assess treatment eligibility and follow-up of H...
<div><p>Background</p><p>An accurate and affordable CD4+ T cells count is an essential tool in the f...
BACKGROUND:A new CD4 point-of-care instrument, the CyFlow miniPOC, which provides absolute and perce...
Flow Cytometry (FCM) is still considered to be the method of choice for accurate CD4 enumeration. Ho...
BACKGROUND: Flow Cytometry (FCM) is still considered to be the method of choice for accurate CD4 enu...
Copyright © 2012 Gerardo Alvarez-Uria et al. This is an open access article distributed under the Cr...
Background: Flow Cytometry (FCM) is still considered to be the method of choice for accurate CD4 enu...
Laboratory follow-up of HIV patients in resource-limited settings requires appropriate instruments f...
thesisImmunophenotyping of helper lymphocytes, known as CD4+ T-cells, is important to assess the fun...
Background: CD4+ T-lymphocyte count (CD4 count) is a standard method used to monitor HIV-infected pa...
Background: CD4+ T-lymphocyte count (CD4 count) is a standard method used to monitor HIV-infected pa...
A CD4 monoclonal antibody which reacts with CD4 lymphocytes but does not react significantly with m...
William R Rodriguez is with Massachusetts General Hospital, Harvard Medical School, and Brigham and ...
Backround: HIV monitoring in resource-constrained settings demands affordable and reliable CD4+ T ly...
Abstract Background The World Health Organization (WHO)'s "3 × 5 program" has spurred efforts to pla...
BackgroundCD4 T-cell counts are still widely used to assess treatment eligibility and follow-up of H...
<div><p>Background</p><p>An accurate and affordable CD4+ T cells count is an essential tool in the f...
BACKGROUND:A new CD4 point-of-care instrument, the CyFlow miniPOC, which provides absolute and perce...
Flow Cytometry (FCM) is still considered to be the method of choice for accurate CD4 enumeration. Ho...
BACKGROUND: Flow Cytometry (FCM) is still considered to be the method of choice for accurate CD4 enu...
Copyright © 2012 Gerardo Alvarez-Uria et al. This is an open access article distributed under the Cr...
Background: Flow Cytometry (FCM) is still considered to be the method of choice for accurate CD4 enu...
Laboratory follow-up of HIV patients in resource-limited settings requires appropriate instruments f...
thesisImmunophenotyping of helper lymphocytes, known as CD4+ T-cells, is important to assess the fun...
Background: CD4+ T-lymphocyte count (CD4 count) is a standard method used to monitor HIV-infected pa...
Background: CD4+ T-lymphocyte count (CD4 count) is a standard method used to monitor HIV-infected pa...
A CD4 monoclonal antibody which reacts with CD4 lymphocytes but does not react significantly with m...
William R Rodriguez is with Massachusetts General Hospital, Harvard Medical School, and Brigham and ...
Backround: HIV monitoring in resource-constrained settings demands affordable and reliable CD4+ T ly...
Abstract Background The World Health Organization (WHO)'s "3 × 5 program" has spurred efforts to pla...
BackgroundCD4 T-cell counts are still widely used to assess treatment eligibility and follow-up of H...